Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1607
    -0.0076 (-0.65%)
     
  • GBP/USD

    1.2370
    -0.0068 (-0.55%)
     
  • Bitcoin GBP

    51,373.59
    +342.79 (+0.67%)
     
  • CMC Crypto 200

    1,374.41
    +61.78 (+4.70%)
     
  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     
  • DOW

    37,986.40
    +211.02 (+0.56%)
     
  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     
  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

Italy's political turmoil push European shares lower

(For a live blog on European stocks, type LIVE/ in an Eikon news window)

Aug 9 (Reuters) - European shares fell on Friday, leading them to post a second straight week of losses, as worries about the stability of Italy's government rattled investors and concerns about Sino-U.S. trade tensions lingered.

Milan's FTMIB index tumbled 1.6% with Italian banks hardest hit after the leader of the ruling League party, Matteo Salvini, pulled his support for the country's governing coalition on Thursday.

Markets have recently been sensitive to political developments in Rome with Italian bond yields jumping each time there were doubts about the soundness of the government.

ADVERTISEMENT

The pan-European STOXX 600 index fell 0.2% after recording its best day in almost two months on Thursday, following upbeat trade data from China and a steadying of its currency.

Also weighing on risk appetite was a Bloomberg report, which said that Washington is delaying a decision about licenses for U.S. firms to restart trade with Huawei Technologies, making investors nervous about a ramp-up of bickering in the ongoing trade dispute.

Helping to limit losses on the benchmark was the healthcare sector, boosted by Novo Nordisk, which beat quarterly operating profit forecasts and raised its 2019 sales outlook. (Reporting by Agamoni Ghosh in Bengaluru; Editing by Bernard Orr)